Humankind Investments LLC Sells 5,105 Shares of Colgate-Palmolive (NYSE:CL)

Humankind Investments LLC trimmed its holdings in shares of Colgate-Palmolive (NYSE:CL) by 61.0% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 3,262 shares of the company’s stock after selling 5,105 shares during the quarter. Humankind Investments LLC’s holdings in Colgate-Palmolive were worth $213,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of CL. Dimensional Fund Advisors LP raised its position in shares of Colgate-Palmolive by 4.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,444,508 shares of the company’s stock worth $185,376,000 after acquiring an additional 94,837 shares in the last quarter. Covestor Ltd grew its stake in Colgate-Palmolive by 71.9% in the first quarter. Covestor Ltd now owns 2,451 shares of the company’s stock valued at $186,000 after purchasing an additional 1,025 shares during the last quarter. Mackenzie Financial Corp raised its holdings in Colgate-Palmolive by 8.5% in the first quarter. Mackenzie Financial Corp now owns 1,882,813 shares of the company’s stock worth $142,774,000 after purchasing an additional 146,936 shares in the last quarter. First Western Trust Bank bought a new stake in shares of Colgate-Palmolive in the 1st quarter valued at about $569,000. Finally, Wsfs Capital Management LLC bought a new position in shares of Colgate-Palmolive during the 1st quarter worth approximately $288,000. Institutional investors own 78.36% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on CL shares. Barclays decreased their price objective on Colgate-Palmolive from $81.00 to $73.00 and set an “equal weight” rating for the company in a report on Thursday, October 12th. StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday, October 30th. Morgan Stanley dropped their target price on shares of Colgate-Palmolive from $89.00 to $85.00 and set an “overweight” rating on the stock in a research report on Monday, October 30th. Royal Bank of Canada raised their price target on shares of Colgate-Palmolive from $79.00 to $80.00 and gave the stock a “sector perform” rating in a report on Monday, October 30th. Finally, Sanford C. Bernstein reduced their target price on Colgate-Palmolive from $82.00 to $76.00 in a research note on Thursday, October 12th. Five research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus price target of $82.57.

Insider Activity at Colgate-Palmolive

In related news, insider John W. Kooyman sold 3,000 shares of Colgate-Palmolive stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of $75.11, for a total transaction of $225,330.00. Following the transaction, the insider now owns 5,347 shares in the company, valued at $401,613.17. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other Colgate-Palmolive news, VP Gregory Malcolm sold 10,493 shares of the firm’s stock in a transaction on Thursday, August 31st. The stock was sold at an average price of $73.90, for a total transaction of $775,432.70. Following the completion of the sale, the vice president now owns 7,852 shares of the company’s stock, valued at $580,262.80. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider John W. Kooyman sold 3,000 shares of the company’s stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $75.11, for a total value of $225,330.00. Following the completion of the transaction, the insider now directly owns 5,347 shares in the company, valued at approximately $401,613.17. The disclosure for this sale can be found here. In the last quarter, insiders sold 93,153 shares of company stock valued at $6,851,466. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Up 0.9 %

CL stock opened at $76.66 on Wednesday. The stock has a market capitalization of $63.12 billion, a P/E ratio of 39.93, a P/E/G ratio of 3.37 and a beta of 0.46. Colgate-Palmolive has a 52 week low of $67.62 and a 52 week high of $82.09. The firm has a 50-day simple moving average of $72.74 and a 200-day simple moving average of $75.29. The company has a quick ratio of 0.74, a current ratio of 1.16 and a debt-to-equity ratio of 21.40.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, October 27th. The company reported $0.86 EPS for the quarter, beating analysts’ consensus estimates of $0.80 by $0.06. The business had revenue of $4.92 billion during the quarter, compared to analysts’ expectations of $4.81 billion. Colgate-Palmolive had a return on equity of 533.40% and a net margin of 8.29%. The business’s revenue was up 10.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.74 earnings per share. Equities analysts forecast that Colgate-Palmolive will post 3.2 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd will be paid a $0.48 dividend. This represents a $1.92 annualized dividend and a dividend yield of 2.50%. The ex-dividend date is Friday, October 20th. Colgate-Palmolive’s dividend payout ratio is currently 100.00%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.